Moderna
MRNA
#1830
Rank
โ‚น972.32 B
Marketcap
โ‚น2,488
Share price
8.67%
Change (1 day)
-31.57%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Revenue for Moderna (MRNA)

Revenue in 2025 (TTM): โ‚น191.91 Billion

According to Moderna 's latest financial reports the company's current revenue (TTM ) is โ‚น197.81 Billion. In 2024 the company made a revenue of โ‚น274.43 Billion a decrease over the revenue in the year 2023 that were of โ‚น562.26 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Moderna from 2018 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น191.91 B-30.07%
2024 โ‚น274.43 B-51.19%
2023 โ‚น562.26 B-64%
2022 โ‚น1.561 T18.32%
2021 โ‚น1.320 T6478.8%
2020 โ‚น20.06 B485.79%
2019 โ‚น3.42 B-60.1%
2018 โ‚น8.58 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Regulus Therapeutics
RGLS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น5.770 T 2,817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚น7.18 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น288.38 B 45.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.064 T 2,460.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
โ‚น51.47 B-73.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.278 T 4,084.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚น17.32 B-91.24%๐Ÿ‡บ๐Ÿ‡ธ USA